Clinical uses and controversies of neuromuscular blocking agents in infants and children

Critical Care Medicine

Volumn 27, Issue 7, 1999, Pages 1358-1368

  Martin, Lynn D ^a,c   Bratton, Susan L ^a   O'Rourke, P Pearl ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Child; Infant; Neuromuscular blocking agents; Neuromuscular depolarizing agents; Neuromuscular junction; Neuromuscular nondepolarizing agents; Newborn; Review

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANESTHETIC AGENT; ATRACURIUM; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CISATRACURIUM; CLINDAMYCIN; DOXACURIUM; FUROSEMIDE; GENTAMICIN; ION CHANNEL; LITHIUM CARBONATE; MAGNESIUM; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PHENYTOIN; POLYMYXIN B; PROCAINAMIDE; QUINIDINE; ROCURONIUM; SUXAMETHONIUM; TETRACYCLINE; THEOPHYLLINE; TOBRAMYCIN; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; VECURONIUM;

ACETYLCHOLINE RELEASE; ARTICLE; BRADYCARDIA; CHILD; CRITICAL ILLNESS; DRUG COST; HEALTH CARE COST; HEART ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPERTENSION; INFANT; MALIGNANT HYPERTHERMIA; NERVE CELL DIFFERENTIATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; SINUS ARREST; TACHYCARDIA;

ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CRITICAL CARE; HUMANS; INFANT; INFANT, NEWBORN; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SYNAPTIC TRANSMISSION;

EID: 0032809678     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199907000-00030     Document Type: Article

References (128)

1. Murray MJ, Strickland RA, Weiler C: The use neuromuscular blocking drugs in the intensive care unit: A U.S. perspective. Intensive Care Med 1993; 19:S40-S44
2. Hall ZW, Sanes JR: Synaptic structure and development: The neuromuscular junction. Cell 1993; 72:99-121
3. Martyn JAJ, White DA, Gronert GA, et al: Up-and-down-regulation of skeletal muscle acetylcholine receptors: Effects on neuromuscular blockers. Anesthesiology 1991; 76:822-843
4. Meretoja OA: Symposium - Muscle relaxants in paediatric anesthesia. Anaesth Intensive Care 1990; 18:440-448
5. Goudsouzian NG: Maturation of the neuromuscular transmission in the infant. Br J Anaesth 1980; 52:205-213
6. Chang CC, Huang M: Turnover of junctional and extrajunctional acetylcholine receptors in the rat diaphragm. Nature 1975; 253:643-644
7. Berg D, Hall ZW: Loss of a bungarotoxin from the junctional and extra-junctional acetylcholine receptors in rat diaphragm muscle in vivo and in organ culture. J Physiol (Lond) 1975; 252:771-779
8. Witzemann V, Barg B, Criado M, et al: Developmental regulation of five subunit specific mRNAs encoding acetylcholine receptor subtypes in rat muscle. FEBS Lett 1989; 242:419-424
9. Mishina M, Takai T, Imoto K, et al: Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 1986; 321: 406-411
10. Gu Y, Hall ZW: Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle. Neuron 1988; 1:117-125
11. Brenner HR, Sakmann B: Neurotrophic control of channel properties at the neuromuscular synapse of the rat muscle. J Physiol (Lond) 1983; 337:159-171
12. Schuetze SM, Role LW: Developmental regulation of nicotinic acetylcholine receptors. Annu Rev Neurosci 1987; 10:403-457
13. Fisher DM, O'Keeffe C, Stanski DR, et al: Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 1982; 57:203-208
14. Keens TG, Bryan AC, Levison H, et al: Developmental pattern of muscle fiber types in human ventilatory muscles. J Appl Physiol 1978; 44:909-913
15. Day NS, Blake GJ, Standaert FG, et al: Characterization of the train-of-four response in fast and slow muscles: Effect of d-tubocurarine, pancuronium, and vecuronium. Anesthesiology 1983; 58:414-417
16. Meakin G, McKiernan EP, Morris P, et al: Dose-response curves for suxamethonium in neonates, infants and children. Br J Anaesth 1989; 62:655-658
17. Meakin G, Walker RWM, Dearlove OR: Myotonic and neuromuscular blocking effects of increased doses of suxamethonium in infants and children. Br J Anaesth 1990; 65: 816-818
18. Liu LMP, DeCook TH, Goudsouzian NG, et al: Dose response to intramuscular succinylcholine in children. Anesthesiology 1981; 55:599-602
19. Fung DL, White Da, Jones BR, et al: The onset of disuse-related potassium efflux to succinylcholine. Anesthesiology 1991; 76: 650-653
20. Gronert GA, Lambert EH, Theye RA: The response of denervated skeletal muscle to succinylcholine. Anesthesiology 1973; 39: 13-22
21. John DA, Tobey RE, Homer LD, et al: Onset of succinylcholine-induced hyperkalemia following denervation. Anesthesiology 1976; 45:294-299
22. Kaus SJ, Rockoff MA: Malignant hyperthermia. Pediatr Clin North Am 1994; 41: 221-237
23. Rosenbert H, Gronert GA: Intractable cardiac arrest in children given succinylcholine [letter]. Anesthesiology 1992; 77:1054
24. Gray T, Halton, J: A milestone in anesthesia (d-tubocurarine chloride)? Proc R Soc Med 1946; 39:400-410
25. Matteo RS, Brotherton WP, Nishitateno K, et al: Pharmacodynamics and pharmokinetics of metocurine in humans: Comparison to d-tubocurarine. Anesthesiology 1982; 57: 183-190
26. Sapirstein A, Hurford WE: Neuromuscular blocking agents in the management of respiratory failure: Indications and treatment guidelines. Crit Care Clin 1994; 10:831-843
27. Basta SJ, Savarese JJ, Ali HH, et al: Clinical pharmacology of doxacurium chloride: A new long-acting nondepolarizing muscle relaxant. Anesthesiology 1988; 69:478-486
28. Sarner JB, Brandom BW, Cook DR, et al: Clinical pharmacology of doxacurium chloride (BW A938U) in children. Anesth Analg 1988; 67:303-306
29. Cook DR, Freeman JA, Lai AA, et al: Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure. Anesth Analg 1991; 72:145-150
30. Baird WLM, Reid AM: The neuromuscular blocking properties of a new steroid compound, pancuronium bromide: A pilot study in man. Br J Anaesth 1967; 39:775-780
31. Meretoja OA, Luosto T: Dose-response characteristics of pancuronium in neonates, infants and children. Anaesth Intensive Care 1990; 18:455-459
32. Levin N, Dillon JB: Cardiovascular effects of pancuronium bromide. Anesth Analg 1971; 50:808-812
33. Brandom BW, Rudd GD, Cook DR: Clinical pharmacology of atracurium in paediatric patients. Br J Anaesth 1983; 55:1178-1213
34. Fisher DM, Canfell PC, Fahey MR, et al: Elimination of atracurium in humans: Contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 1986; 65:6-12
35. Nigrovic V, Fox JL: Atracurium decay and the formation of laudanosine in humans. Anesthesiology 1991; 74:446-454
36. Hennis PJ, Fahey MR, Canfell PC, et al: Pharmacology of laudanosine in dogs. Anesthesiology 1986; 65:56-60
37. Yate PM, Flynn PJ, Arnold RW, et al: Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth 1987; 59:211-217
38. Brandom BW, Cook DR, Woelfel SK, et al: Pharmacokinetics of atracurium in anesthetized infants and children. Br J Anaesth 1986; 58:1210-1213
39. Fisher DM, Cantell PC, Spellman MJ, et al: Pharmacokinetics and pharmacodynamics of atracurium in infants and children. Anesthesiology 1990; 73:33-37
40. Brandom BW, Cook DR, Woelfel SK, et al: Atracurium infusion requirements in children during halothane, isoflurane and narcotic anesthesia. Anesth Analg 1985; 64: 471-476
41. Kalli I, Meretoja OA: Infusion of atracurium in neonates, infants and children: A study of dose requirements. Br J Anaesth 1988; 60: 651-654
42. Tabardel Y, Paquay T, Senterre J: Prolonged infusion of atracurium in an infant. Dev Pharmacol Ther 1990; 15:52-56
43. Kashino OT, Darowski MJ, Morris P, et al: Dose requirements of atracurium in paediatric intensive care patients. Br J Anaesth 1991; 67:781-783
44. Lien CA, Belmont MR, Abalos A, et al: The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995; 82: 1131-1138
45. Eastwood NB, Boyd AH, Parker CJR, et al: Pharmacokinetics of 1R-cis 1′R-cis atracurium besylate (51W89) and plasma laudanosine concentration in health and chronic renal failure. Br J Anaesth 1995; 75:431-435
46. Belmont MR, Lien CA, Quessy S, et al: The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/ opioid/barbiturate anesthesia. Anesthesiology 1995; 82:1139-1145
47. ™): A new nondepolarizing muscle relaxant. Anesthesiology 1981; 55:6-11
48. Bencini AF, Scaf AHJ, Sohn YJ, et al: Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 1986; 58: 988-995
49. Segredo V, Shin Y-S, Sharma ML, et al: Pharmacokinetics, neuromuscular effects, and biodisposition of 3-desacetylvecuronium (Org 7268) in cats. Anesthesiology 1991; 74:1052-1059
50. Segredo V, Caldwell JE, Matthay MA, et al: Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327:524-528
51. Meistelman C, Agoston S, Kersten UW, et al: Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized children. Anesth Analg 1986; 65: 1319-1323
52. Meretoja OA: Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants? Br J Anaesth 1989; 62:184-187
53. Fisher DM, Castagnoli K, Miller RD: Vecuronium kinetics and dynamics in anesthetized infants and children. Clin Pharmacol Ther 1985; 37:402-406
54. Sloan MH, Lerman J, Bissonnette B: Pharmacodynamics of high-dose vecuronium in children during balanced anesthesia. Anesthesiology 1991; 74:65-69
55. Wierda JMKH, DeWit APM, Kuizenga K, et al: Clinical observations on the neuromuscular blocking action of ORG 9426, a new steroidal nondepolarizing agent. Br J Anaesth 1990; 64:521-523
56. Bartkowski RR, Witkowski TA, Azad S, et al: Rocuronium onset of action: A comparison with atracurium and vecuronium. Anesth Analg 1993; 77:574-578
57. Pühringer FK, Khuenl-Brady KS, Koller J, et al: Evaluation of the endotracheal intubating conditions of rocuronium (ORG 9426) and succinylcholine in outpatient surgery. Anesth Analg 1992; 75:37-40
58. 2-sufentanil anesthesia. Anesth Analg 1994; 78:318-321
59. Woelfel SK, Brandom BW, Cook DR, et al: Effects of bolus administration of ORG-9426 in children during nitrous oxidehalothane anesthesia. Anesthesiology 1992; 76:939-942
60. Gronert BJ, Brandom BW: Neuromuscular blocking drugs in infants and children. Pediatr Clin North Am 1994; 41:73-91
61. Meistelman C, Plaud B, Donati F: Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anaesth 1992; 39:665-669
62. Cantineau JP, Porte F, d'Honneur G, et al: Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anesthetized patients. Anesthesiology 1994; 81:585-590
63. Wright PMC, Caldwell JE, Miller RD: Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans. Anesthesiology 1994; 81:1110-1115
64. Savarese JJ, Ali HH, Basta SJ, et al: The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U): A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68:723-732
65. Goudsouzian NG, d'Hollander AA, Viby-Mogensen J: Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993; 77:183-185
66. Lien CA, Schmith VD, Embree PB, et al: The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 1994; 80:1296-1302
67. Brandom BW, Sarner JB, Woelfel SK, et al: Mivacurium infusion requirements in pediatric surgical patients during nitrous oxide-halothane and during nitrous oxide-narcotic anesthesia. Anesth Analg 1990; 71: 16-22
68. Klessig HT, Geiger HJ, Murray MJ, et al: A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants. Crit Care Med 1992; 20: 1341-1345
69. Prielipp RC, Coursin DB: Applied pharmacology of common neuromuscular blocking agents in critical care. New Horiz 1994; 2:34-47
70. Hansen-Flaschen JH, Brazinsky S, Basile C, et al: Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. JAMA 1991; 266:2870-2875
71. Kelly MA, Finer NN: Nasotracheal intubation in the neonate: Physiologic responses and effects of atropine and pancuronium. J Pediatr 1984; 105:303-309
72. Friesen RH, Honda AT, Thieme RE: Changes in anterior fontanel pressure in preterm neonates during tracheal intubation. Anesth Analg 1987; 66:874-878
73. Stow PJ, McLeod ME, Burrows FA, et al: Anterior fontanel pressure responses to tracheal intubation in the awake and anaesthetized infant. Br J Anaesth 1988; 60:167-170
74. Barrington KJ, Finer NN, Etches PC: Succinylcholine and atropine for premedication of the newborn infant before nasotracheal intubation: A randomized controlled trial. Crit Care Med 1989; 17:1293-1296
75. Millar C, Bissonnette B: Awake intubation increases intracranial pressure without affecting cerebral blood flow velocity in infants. Can J Anaesth 1994; 41:281-287
76. Schoenfeld PS, Baker MD: Management of cardiopulmonary and trauma resuscitation in the pediatric emergency department. Pediatrics 1993; 91:726-729
77. Gnauck K, Lungo JB, Scalzo A, et al: Emergency intubation of the pediatric medical patient: Use of anesthetic agents in the emergency department. Ann Emerg Med 1994; 23:1242-1247
78. Nakayama DK, Waggoner T, Venkataraman ST, et al: The use of drugs in emergency airway management in pediatric trauma. Ann Surg 1992; 216:205-211
79. Yamamoto LG, Yim GK, Britten AG: Rapid sequence anesthesia induction for emergency intubation. Pediatr Emerg Care 1990; 6:200-213
80. Ma OJ, Bentley B II, Debehnke DJ: Airway management practices in emergency medicine residencies. Am J Emerg Med 1995; 13:501-504
81. Manthouos CA, Hall JB, Kushner R, et al: The effect of mechanical ventilation on oxygen consumption in critically ill patients. Am J Respir Crit Care Med 1995; 151: 210-214
82. Murphy-Macabobby M, Marshall WJ, Scheider C, et al: Neuromuscular blockade in aeromedical airway management. Ann Emerg Med 1992; 21:664-668
83. Tuxen DV: Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994; 150: 870-874
84. Bidani A, Tzouanakis AE, Cardenas VJ, et al: Permissive hypercapnia in acute respiratory failure. JAMA 1994; 272:957-962
85. Fox WW, Duara S: Persistent pulmonary hypertension in the neonate: Diagnosis and management. J Pediatr 1983; 103:505-514
86. 2 on pulmonary and systemic hemodynamics after surgery in children with congenital heart disease and pulmonary hypertension. J Pediatr 1988; 113: 474-479
87. Arnold JH, Hanson JH, Toro-Figuero LO, et al: Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994; 22:1530-1539
88. Fuhrman BP, Paczan PR, DeFrancisis M: Perfluorocarbon-associated gas exchange. Crit Care Med 1991; 19:712-722
89. Zeitouni AG, Manoukian J: Severe complication of the anterior cricoid split operation and single-stage laryngotracheoplasty. Ann Otol Rhinol Laryngol 1994; 103:723-725
90. Denmark SM, Georgeson KE: Primary closure of gastroschisis. Arch Surg 1983; 118: 66-68
91. Davidson JE: Neuromuscular blockade: Indications, peripheral nerve situation, and other concurrent interventions. New Horiz 1994; 2:75-84
92. Ali HH, Savarese JJ, Lebowitz PW, et al: Twitch, tetanus and train-of-four as indices of recovery from nondepolarizing neuromuscular blockade. Anesthesiology 1981; 54:294-297
93. Hunter JM: Resistance to nondepolarizing neuromuscular blocking agents [editorial]. Br J Anaesth 1991; 67:511-514
94. Hogue CW Jr, Ward JM, Itani MS, et al: Tolerance and upregulation of acetylcholine receptors follow chronic infusion of d-tubocurarine. J Appl Physiol 1992; 72: 1326-1331
95. Armstrong DK, Crisp CB: Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care. New Horiz 1994; 2:85-93
96. Clarens DM, Kelly KJ, Gilliland SS, et al: A retrospective analysis of long-term use of nondepolarizing blocking agents in the intensive care unit, and guidelines for drug selection. Pharmacotherapy 1993; 13: 647-655
97. Sinha SK, Levene MI: Pancuronium bromide induced joint contractures in the newborn. Arch Dis Child 1984; 59:73-75
98. Rutledge ML, Hawkins EP, Langston C: Skeletal muscle growth failure induced in premature newborn infants by prolonged pancuronium treatment. J Pediatr 1986; 109:883-886
99. Parker MM, Schubert W, Shelhamer JH, et al: Perceptions of a critically ill patient experiencing therapeutic paralysis in an ICU. Crit Care Med 1984; 12:69-71
100. Harwood TN, Moorthy SS: Prolonged vecuronium-induced neuromuscular blockade in children. Anesth Analg 1989; 68:534-536
101. Pascucci RC: Prolonged weakness after extended mechanical ventilation in a child. Crit Care Med 1990; 18:1181-1182
102. Griffin D, Fairman N, Coursin D, et al: Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 1992; 102: 510-514
103. Hansen-Flaschen J, Cowen J, Raps EC: Neuromuscular blockade in the intensive care unit: More than we bargained for. Am Rev Respir Dis 1993; 147:234-236
104. Meyer KC, Prielipp RC, Grossman JE, et al: Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994; 78:772-774
105. Marik PE: Doxacurium-corticosteroid acute myopathy: Another piece to the puzzle. Crit Care Med 1996; 24:1266-1267
106. Rudis MI, Guslits BJ, Peterson EL, et al: Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. Crit Care Med 1996; 24:1749-1756
107. Watling SM, Dasta JF: Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of the literature. Crit Care Med 1994; 22: 884-893
108. Levene MI, Quinn MW: Use of sedatives and muscle relaxants in newborn babies receiving mechanical ventilation. Arch Dis Child 1992; 67:870-873
109. Greenough A, Morley CJ, Wood S, et al: Pancuronium prevents pneumothoraces in ventilated premature babies who actively expire against positive pressure inflation. Lancet 1984; i:1-3
110. Stark AR, Bascom R, Frantz ID III: Muscle relaxation in mechanically ventilated infants. J Pediatr 1979; 94:439-443
111. Bancalari E, Gerhardt T, Feller R, et al: Muscle relaxation during IPPV in prematures with RDS. Abstr. Pediatr Res 1980; 14:590
112. Pollitzer MJ, Shaw DG, Reynolds EOR, et al: Pancuronium during mechanical ventilation speeds recovery of lungs of infants with hyaline membrane disease. Lancet 1981; i:346-348
113. Bhutani VK, Abbasi S, Sivieri EM: Continuous skeletal muscle paralysis: Effect on neonatal pulmonary mechanics. Pediatrics 1988; 81:419-422
114. Miller J, Law AB, Parker RA, et al: Effects of morphine and pancuronium on lung volume and oxygenation in premature infants with hyaline membrane disease. J Pediatr 1994; 125:97-103
115. Crone RK, Favorito J: The effects of pancuronium bromide on infants with hyaline membrane disease. J Pediatr 1980; 97: 991-993
116. Runkle B, Bancalari E: Acute cardiopulmonary effects of pancuronium bromide in mechanically ventilated newborn infants. J Pediatr 1984; 104:614-617
117. Finer NN, Tomney PM: Controlled evaluation of muscle relaxation in the ventilated neonate. Pediatrics 1981; 67:641-646
118. Shaw NJ, Cooke RWI, Gill AB, et al: Randomized trial of routine versus selective paralysis during ventilation for neonatal respiratory distress syndrome. Arch Dis Child 1993; 69:479-482
119. Perlman JM, McMenamin JB, Volpe JJ: Fluctuating cerebral blood-flow velocity in respiratory-distress syndrome: Relationship to the development of intraventricular hemorrhage. N Engl J Med 1983; 309: 204-209
120. Perlman JM, Goodman S, Kreusser KL, et al: Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood-flow velocity in preterm infants with respiratory distress syndrome. N Engl J Med 1985; 312:1353-1357
121. Costakos DT, Blackwell CE, Krauss AN, et al: Aortic root blood flow increases after pancuronium in neonates with hyaline membrane disease. Crit Care Med 1991; 19: 187-190
122. Cabal LA, Siassi B, Artal R, et al: Cardiovascular and catecholamine changes after administration of pancuronium in distressed neonates. Pediatrics 1985; 75:284-287
123. Greenough A, Gamsu HR, Greenall F: Investigation of the effects of paralysis by pancuronium on heart rate variability, blood pressure and fluid balance. Acta Paediatr Scand 1989; 78:829-834
124. Eldadah MK, Newth CJL: Vecuronium by continuous infusion for neuromuscular blockade in infants and children. Crit Care Med 1989; 17:989-992
125. Fitzpatrick KTJ, Black GW, Crean PM, et al: Continuous vecuronium infusion for prolonged muscle relaxation in children. Can J Anaesth 1991; 38:169-174
126. Kushimo OT, Darowski MJ, Morris P, et al: Dose requirements of atracurium in paediatric intensive care patients. Br J Anaesth 1991; 67:781-783
127. Tobias JD, Lynch A, McDuffee A, et al: Pancuronium infusion for neuromuscular block in children in the pediatric intensive care unit. Anesth Analg 1995; 81:13-16
128. Mickell JJ, Pedigo SA, Lucking SE, et al: Age-related differences in the use of morphine, diazepam, and pancuronium for mechanically ventilated children. Dev Pharmacol Ther 1990; 14:20-28